Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies

IntroductionThe impact of a pandemic on the mental health of the population is to be expected due to risk factors such as social isolation. Prescription drug abuse and misuse could be an indicator of the impact of the COVID-19 pandemic on mental health. Community pharmacists play an important role i...

Full description

Bibliographic Details
Main Authors: Maria Perelló, Karla Rio-Aige, Pilar Rius, Guillermo Bagaría, Anna M. Jambrina, Montse Gironès, Francisco José Pérez-Cano, Manel Rabanal
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1116337/full
_version_ 1828033248883638272
author Maria Perelló
Maria Perelló
Karla Rio-Aige
Karla Rio-Aige
Pilar Rius
Guillermo Bagaría
Anna M. Jambrina
Anna M. Jambrina
Montse Gironès
Francisco José Pérez-Cano
Francisco José Pérez-Cano
Manel Rabanal
Manel Rabanal
Manel Rabanal
author_facet Maria Perelló
Maria Perelló
Karla Rio-Aige
Karla Rio-Aige
Pilar Rius
Guillermo Bagaría
Anna M. Jambrina
Anna M. Jambrina
Montse Gironès
Francisco José Pérez-Cano
Francisco José Pérez-Cano
Manel Rabanal
Manel Rabanal
Manel Rabanal
author_sort Maria Perelló
collection DOAJ
description IntroductionThe impact of a pandemic on the mental health of the population is to be expected due to risk factors such as social isolation. Prescription drug abuse and misuse could be an indicator of the impact of the COVID-19 pandemic on mental health. Community pharmacists play an important role in addressing prescription drug abuse by detecting signs and behaviors that give a clearer indication that a drug abuse problem exists.MethodsA prospective observational study to observe prescription drug abuse was conducted from March 2020 to December 2021 to compare with data obtained in the previous 2 years, through the Medicine Abuse Observatory, the epidemiological surveillance system set up in Catalonia. Information was obtained through a validated questionnaire attached on a web-based system and data collection software. A total of 75 community pharmacies were enrolled in the program.ResultsThe number of notifications during the pandemic period (11.8/100.000 inhabitants) does not indicate a significant change compared with those from pre-pandemic period, when it was 12.5/100.000 inhabitants. However, the number of notifications during the first wave when lockdown was in place stood at 6.1/100,000 inhabitants, significantly lower than in both the pre-pandemic and the whole of the pandemic periods. Regarding the patient's profile, it was observed that the proportion of younger patients (<25 and 25–35) rose in contrast to older ones (45–65 and >65). The use of benzodiazepines and fentanyl increased.ConclusionsThis study has made it possible to observe the impact of the pandemic caused by COVID-19 on the behavior of patients in terms of use of prescription drugs through analysis of the trends of abuse or misuse and by comparing them with the pre-pandemic period. Overall, the increased detection of benzodiazepines has pointed out stress and anxiety generated by the pandemic.
first_indexed 2024-04-10T15:17:07Z
format Article
id doaj.art-514410282ddd48438590cb094f5fc30e
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-10T15:17:07Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-514410282ddd48438590cb094f5fc30e2023-02-14T18:21:06ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-02-011110.3389/fpubh.2023.11163371116337Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmaciesMaria Perelló0Maria Perelló1Karla Rio-Aige2Karla Rio-Aige3Pilar Rius4Guillermo Bagaría5Anna M. Jambrina6Anna M. Jambrina7Montse Gironès8Francisco José Pérez-Cano9Francisco José Pérez-Cano10Manel Rabanal11Manel Rabanal12Manel Rabanal13Council of the Pharmacist's Association of Catalonia, Barcelona, SpainPhysiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, SpainPhysiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, SpainInstitute of Research in Nutrition and Food Safety (INSA), Santa Coloma de Gramenet, SpainCouncil of the Pharmacist's Association of Catalonia, Barcelona, SpainCouncil of the Pharmacist's Association of Catalonia, Barcelona, SpainPhysiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, SpainDirectorate-General for Healthcare Planning and Regulation, Ministry of Health, Government of Catalonia, Barcelona, SpainCouncil of the Pharmacist's Association of Catalonia, Barcelona, SpainPhysiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, SpainInstitute of Research in Nutrition and Food Safety (INSA), Santa Coloma de Gramenet, SpainPhysiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, SpainInstitute of Research in Nutrition and Food Safety (INSA), Santa Coloma de Gramenet, SpainDirectorate-General for Healthcare Planning and Regulation, Ministry of Health, Government of Catalonia, Barcelona, SpainIntroductionThe impact of a pandemic on the mental health of the population is to be expected due to risk factors such as social isolation. Prescription drug abuse and misuse could be an indicator of the impact of the COVID-19 pandemic on mental health. Community pharmacists play an important role in addressing prescription drug abuse by detecting signs and behaviors that give a clearer indication that a drug abuse problem exists.MethodsA prospective observational study to observe prescription drug abuse was conducted from March 2020 to December 2021 to compare with data obtained in the previous 2 years, through the Medicine Abuse Observatory, the epidemiological surveillance system set up in Catalonia. Information was obtained through a validated questionnaire attached on a web-based system and data collection software. A total of 75 community pharmacies were enrolled in the program.ResultsThe number of notifications during the pandemic period (11.8/100.000 inhabitants) does not indicate a significant change compared with those from pre-pandemic period, when it was 12.5/100.000 inhabitants. However, the number of notifications during the first wave when lockdown was in place stood at 6.1/100,000 inhabitants, significantly lower than in both the pre-pandemic and the whole of the pandemic periods. Regarding the patient's profile, it was observed that the proportion of younger patients (<25 and 25–35) rose in contrast to older ones (45–65 and >65). The use of benzodiazepines and fentanyl increased.ConclusionsThis study has made it possible to observe the impact of the pandemic caused by COVID-19 on the behavior of patients in terms of use of prescription drugs through analysis of the trends of abuse or misuse and by comparing them with the pre-pandemic period. Overall, the increased detection of benzodiazepines has pointed out stress and anxiety generated by the pandemic.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1116337/fullCOVIDmedicine abuseobservatorydrugbenzodiazepinescommunity pharmacy
spellingShingle Maria Perelló
Maria Perelló
Karla Rio-Aige
Karla Rio-Aige
Pilar Rius
Guillermo Bagaría
Anna M. Jambrina
Anna M. Jambrina
Montse Gironès
Francisco José Pérez-Cano
Francisco José Pérez-Cano
Manel Rabanal
Manel Rabanal
Manel Rabanal
Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies
Frontiers in Public Health
COVID
medicine abuse
observatory
drug
benzodiazepines
community pharmacy
title Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies
title_full Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies
title_fullStr Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies
title_full_unstemmed Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies
title_short Changes in prescription drug abuse during the COVID-19 pandemic evidenced in the Catalan pharmacies
title_sort changes in prescription drug abuse during the covid 19 pandemic evidenced in the catalan pharmacies
topic COVID
medicine abuse
observatory
drug
benzodiazepines
community pharmacy
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1116337/full
work_keys_str_mv AT mariaperello changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT mariaperello changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT karlarioaige changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT karlarioaige changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT pilarrius changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT guillermobagaria changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT annamjambrina changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT annamjambrina changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT montsegirones changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT franciscojoseperezcano changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT franciscojoseperezcano changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT manelrabanal changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT manelrabanal changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies
AT manelrabanal changesinprescriptiondrugabuseduringthecovid19pandemicevidencedinthecatalanpharmacies